GLPBio

Apoptosis

Read More about this category

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

 

References:

1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.

2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.

3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.

4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.

5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Research Areas

Products Related to Apoptosis(3030)

  • GN10535 structure
    GN10535Cucurbitacin B
    CAS: 6199-67-3
    Purity: >98.00%

    Cucurbitacin B is a kind of tetracyclic triterpenoid compounds isolated from cucurbitaceae, and exhibits a wide range of biological activities.

  • GN10538 structure
    GN10538Ginsenoside Rh1
    CAS: 63223-86-9
    Purity: >98.00%
  • GN10539 structure
    GN10539Bergenin
    CAS: 477-90-7
    Purity: >99.50%
  • GN10543 structure
    GN10543caudatin
    CAS: 38395-02-7
    Purity: >98.00%
  • GN10544 structure
    GN10544Ginsenoside Rg1
    CAS: 22427-39-0
    Purity: >98.00%

    Ginsenoside Rg1은 인삼에서 발견된 주요 활성 성분 중 하나로 광범위한 생물학적 활동을 가진 자연 제품으로 알려진 스테로이드 글리코사이드류이다.

  • GN10547 structure
    GN10547β-Sitosterol
    CAS: 83-46-5
    Purity: >98.00%

    β-Sitosterol은 식물에서 유래된 자연 스테롤로 암 발병을 억제하는 등 다양한 생물학적 활성을 가지고 있다. β-Sitosterol은 또한 심혈관 건강에 미치는 영향을 연구하기 위해 일반적으로 사용된다.

  • GN10560 structure
    GN10560α-hederin
    CAS: 27013-91-8
    Purity: >98.00%
  • GN10561 structure
    GN10561astragalin
    CAS: 480-10-4
    Purity: >98.00%

    Astragalin은 강력한 항산화 및 항염증 활성을 가진 천연 플라보노이드 화합물이고 암과 심혈관 질환을 포함한 다양한 질환에서 잠재적인 치료 응용을 보여주었다.

  • GN10584 structure
    GN10584Ginsenoside Rk1
    CAS: 494753-69-4
    Purity: >98.00%
  • GN10585 structure
    GN10585Tetramethylpyrazine
    CAS: 1124-11-4
    Purity: >99.50%

    Tetramethylpyrazine은 항염증, 항산화, 항종양, 자가포식 조절, 혈관확장, 혈관생성 조절, 미토콘드리아 손상 억제, 내피 보호 및 신경 보호 활성을 가지고 있는 Chuanxiong 뿌리줄기에서 분리된 알칼로이드이다.

  • GN10629 structure
    GN106295,7-dihydroxychromone
    CAS: 31721-94-5
    Purity: >99.00%

    5,7-dihydroxychromone은 땅콩 껍질에서 유래한 플라보노이드 분해 생성물로 벨벳잎, 옥수수, 땅콩 및 밀의 배아근 신장을 억제한다.

  • GN10632 structure
    GN10632Betulin
    CAS: 473-98-3
    Purity: >98.00%
  • GN10634 structure
    GN10634Myricetin
    CAS: 529-44-2
    Purity: >98.00%

    Myricetin은 식물에 흔히 발견되는 자연 플라보노이드로 항산화, 항염증, 항종양 활성을 가지고 있어 미토겐 활성화 단백질 키나아제 (MEK1)과 JB6 P+ 쥐 표피 세포의 암성 전환을 억제하는 새로운 억제제로 작용한다.

  • GN10639 structure
    GN10639Methyl protodioscin
    CAS: 54522-52-0
    Purity: >98.00%
  • GN10645 structure
    GN10645Jaceosidin
    CAS: 18085-97-7
    Purity: >98%
  • GN10648 structure
    GN10648Rosmarinic acid
    CAS: 20283-92-5
    Purity: >98.00%

    Rosmarinic acid은 식물에서 널리 퍼져 있는 페놀성 에스테르 화합물이다. Rosmarinic acid은 항바이러스, 항균, 항염증, 신경보호, 항암, 항지질과산화, 세포사멸유도 및 항산화 활성을 가지고 있다.

  • GN10650 structure
    GN10650Ziyuglycoside II
    CAS: 35286-59-0
    Purity: >98.00%
  • GN10654 structure
    GN10654(+)-Corynoline
    CAS: 18797-79-0
    Purity: >98.00%
  • GN10666 structure
    GN10666Isoalantolactone
    CAS: 470-17-7
    Purity: >98.00%
  • GN10667 structure
    GN10667Calycosin
    CAS: 20575-57-9
    Purity: >98.00%

    Calycosin은 자연스럽게 아스트라갈러스 멤브라나세우스에 존재하는 천연 이소플라보노이드로 항산화, 항염증 및 항세포 사멸 특성을 지닌다

  • GN10681 structure
    GN10681Sophocarpine
    CAS: 6483-15-4
    Purity: >98.00%
  • GN10686 structure
    GN10686Ginsenoside Rh2
    CAS: 78214-33-2
    Purity: >99.50%
  • GN10702 structure
    GN10702Asiatic acid
    CAS: 464-92-6
    Purity: >99.00%

    Asiatic acid은 EGFR 활성을 억제하는 펜타사이클릭 트리테르페노이드로 야생형 EGFR과 T790M/L858R EGFR에 대한 IC50 값은 각각 0.035nM과 0.348nM이다.

  • GN10709 structure
    GN10709Polyphyllin A
    CAS: 50773-41-6
    Purity: >98.00%